Several studies have demonstrated that subjects with PWS, not receiving hGH therapy, had lower insulin levels and greater insulin sensitivity compared to controls matched for degree of obesity [86,87]. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.